chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe leg cramps off and on from 4AM TO 9Pm on Friday August 31, 2018. Also felt extremely cold, fatigued and headachy during those hours. I experience leg cramps and medicate for them. These were of the longest duration and greatest severity of my life.
Information has been received concerning a pt who was vaccinated and approximately 2 weeks later the pt developed 13 fluid filled vesicles located on her back, left thigh, and face. Unspecified medical attention was sought. It was noted the vesicles crusted over and on an unspecified date the pt recovered.
On Saturday 10/2/21 afternoon I started feeling very emotional and depressed. I could not stop crying and just wanted to be alone. I went to sleep at 1930 and woke up the following morning around 0800. I still felt very emotional, and was very tearful. Around 1230 I started feeling less depressed, but was still very tense. I felt out of character those two days 10/2-10/3. Today, 10/4, I feel back to "normal".
Respiratory distress; red in face & coughing. Sats 80's & HR 180's. EPI Jr Pen IM administered. Breath sounds tight. Albuterol and racepinephrine nebulizer given. 12.6 mg Dexamethasone IM given. Breath sounds clear. HR 130's Sats 96-97% BENADRYL 25mg po given itching.
Receive their 4th dose of the Pfizer Covid-19 vaccine; Fever; Chills; Headache; Body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 70 year-old male patient received bnt162b2 (BNT162B2), administration date 24Feb2022 (Batch/Lot number: unknown) as dose 4 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Unknown Manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 2, Unknown Manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 3, Got the booster , Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset 24Feb2022, outcome "unknown", described as "Receive their 4th dose of the Pfizer Covid-19 vaccine"; PYREXIA (non-serious) with onset Feb2022, outcome "unknown", described as "Fever"; CHILLS (non-serious) with onset Feb2022, outcome "unknown", described as "Chills"; HEADACHE (non-serious) with onset Feb2022, outcome "unknown", described as "Headache"; PAIN (non-serious) with onset Feb2022, outcome "unknown", described as "Body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 3 weeks following the administration of second dose of Moderna COVID-19 vaccine, this patient developed  epistaxis, blood blisters on his skin and in his mouth, petechiae over his legs, and bleeding of his gums. Lab work revealed severe thrombocytopenia with a platelet count of "0".
This case was reported by a healthcare professional and described the occurrence of sore arm in a 45 year old female subject who was vaccinated with influenza virus vaccine (Fluarix, GlaxoSmithKline) for prophylaxis. The subject had not previously received an influenza virus vaccine. The subject had not previously received an influenza virus vaccine immunization. On 16, November 2006 at 8;36 p.m the subject received a dose of Fluarix in an unspecified arm. On an unspecified date on or after 16, November 2006, less than one week after vaccination with Fluarix, the subject experienced injection site redness, heat at injection site. and "her entire arm was sore. "The subject was seen at a physician's office. The healthcare professional reported that, " the patient's doctor stated that she may be allergic to the preservative in the vaccination." The events resolved in approximately one week on an unspecified date in 2006. The healthcare professional considered the events were probably related to vaccination with Fluarix. Follow-up information received on 26 February 2007 indicated that the events began on 17, November 2006, the day after vaccination with Fluarix. The events completely resolved by 24, November 2006. An additional event of arm swelling was reported. In the reporter's opinion, the events were related to treatment with Fluarix.
This spontaneous report as received from a healthcare professional refers to multiple unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M040412 for prophylaxis.
Vomited x2 approx 12 hours after second dose; headache; body aches; low grade fever 99.9; This is a spontaneous report from a contactable Nurse. A 38-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in arm left on 20Feb2021 at 10:00 AM (at the age of 38-year-old) as dose 2, single for COVID-19 immunization. Medical history included seasonal allergies, iron deficiency. Patient had no known drug it food allergies. The patient concomitant medications included fluticasone propionate (FLONASE), loratadine (CLARITIN), multivitamin (VITAMINS NOS) 1 a day. The patient did not receive any other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination. Patient was not COVID tested post vaccination. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL8982), via an unspecified route of administration, administered in arm left on 24Jan2021 at 02:00 PM as dose 1, single for COVID-19 immunization. The patient experienced vomited x2 approx 12 hours after second dose, headache, body aches, low grade fever 99.9, all on 20Feb2021 at 22:00 (10:00 PM). Adverse event: Vomited x2 approx 12 hours after second dose, headache, body aches, low grade fever 99.9. The patient underwent lab tests and procedures which included low grade fever was 99.9 on 20Feb2021. The patient did not receive treatment for the events. Outcome of the events was recovering.  Follow-up (PRD/SRD 22Jul2021): Follow-up attempts completed. No further information expected.
Pt noticed redness, swelling and warmth at left deltoid injection site 48 hours after shot with some mild difficulty swallowing. Placed cold packs; cannot take oral Benadryl; will try topical.
Within 2 hours of injection I developed severe flu-like symptoms and a significant injection site reaction. Within 3 days was feeling fine and site was only pink. A week after injection I developed full blown cellulitis out of the blue and had to get antibiotics prescribed. After 4 days on antibiotics, it resolved, then the following day the cellulitis symptoms returned below original cellulitis location.
Temperature 101 10/25-10/26/02. Then broke out in varicella type rash 12/26-12/27/02 about 100 lesions.
When patient being scheduled for next appointment, reported feeling dizzy.  Nurse assessed patient vital signs with BP 86/60.  Otherwise normal assessment except for pt reports of dizziness.  Nurse continued assessment and BP increased to 96/60.  Pt reported BP "usually runs low".
Redness,soreness,swelling ,itching at site of injection  1 1/2 " by  1 1/2 "
Information has been received from a physician concerning a 71 year old female with a history of breast cancer who was recently vaccinated with a dose of ZOSTAVAX (Oka/Merck). There was no concomitant medication. About one week post vaccination the patient developed pain and went to the emergency room. The physician at the ER felt the pain might be caused by Shingles still in the prodromal stage. The patient was placed on an anti-viral medication and released. The patient was recovering from pain. No product quality complaint was involved. Additional information has been requested.
Patient said he felt sick within a couple hours of getting vaccine. He could barely walk up the stairs, his arm ached and his joints hurt.
Patient fainted within 5 min of vaccine administration. Fell on the floor face down. Lost consciousness for a few seconds. He was saying he felt very dizzy and sweaty once he regained his consciousness, Pt was taken to the hospital by EMT
This patient received his second covid-19 vaccine at a retail pharmacy on 10/10/21 and came to Hospital's Emergency Department on 10/13/21 due to developed chills, headache, fatigue, myalgias and arthralgias and then ultimately developed some stabbing chest pain as well as heaviness in his chest. Due to no beds being available at this facility, the patient was transferred to another Hospital.
within 2 weeks of injection, patient feels he had worsening Fatigue, Weakness, Tremulousness, confusion.
This spontaneous report has been received from a registered nurse via Company Representative reporting that the color of the packaging for PROQUAD (Merck) and M-M-R II product were very similar and could not be confused. No instances where there had been product confusion were reported. No adverse effect was reported. No patient involved. Additional information has been requested.
I noticed a rash on my arms, legs, and neck on November 21, 2022, I experienced itching from the rash I was using a steroid cream called Triamcinolone; Dexamethasone; for the symptoms. The still persist it has not cleared I'm also seeing a Dermatologist.
patient had a rash that developped 5 inches below injection site.  recommended the patient to use hydrocortisone and cold compresses. patient is debating seeing her physician for an antibiotic
Health business professional calling to report AE for improperly stored vaccines. Date of administration is unknown so AE onset date is unknown by reporter.; No additional AE information; This spontaneous report was received from a health business professional and referred to a patient of unknown gender, currently was 4 years old. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.   On an unknown date, the patient was vaccinated improperly stored with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection (lot #U022727, expiration date: 16-JAN-2023; strength, and route of administration were not provided) administered for prophylaxis) (product storage error).  It was reported that the suspect vaccine was exposed to a temperature of 6 Fahrenheit (F) up to 14 F (minus 14 degree Celsius up to minus 10 degree Celsius) (minus 11.6) for a time frame of 30 minutes. There were no previous temperature excursions.   No additional adverse event (AE) information or other AE was provided.   This is one of the several cases reported by the same reporter.; Sender's Comments:  US-009507513-2206USA004544:
Post vax, the patient developed redness at the injection site. The patient sought unspecified medical attention. Follow up information from the health care facility indicated that the patient received another shot with no problems. It was reported that the reporter "didn't remember the name of the patient". No further information is expected.
4 days after vaccine I woke up with vertigo, feeling off balance, full head. Noticed tinnitus in both ears along with tingling in face. Tinnitus remains constant 16 days after onset with no change.
Patient HAS PRESENTED WITH BODY RASH, WITH SOME BLISTERS ON THE FACE, 5 DAYS AFTER THE THIRD DOSE WAS ADMINISTERED. Patient CAME TO MEDICAL Clinic TODAY, STATES HE HAS NOT BEEN TO THE HOSPITAL AND DOES NOT HAVE A PHYSICIAN. THIS Patient DOES NOT EXHIBIT ANY SIGNS OF RESPRITORY DISTRESSAT THIS TIME, AnD DENIES ANY PRIOR THIS INTERVIEW.
Report described abdominal pain in a 51 year old male who received hep A vaccine. Allergies and concomitant medications were not specified. Per the vaccinee's daughter, the vaccinee 'was having problems before in this area (liver).' There was no illness at the time of vaccination. Per the reporter, the vaccinee denied any problems prior to the administration of Havrix, and hep B vaccine recombinant (Engerix-B). this report has been submitted by the reporter also to the Centers for Disease Control. On 03/26/2001 15:30, the vaccinee received his first IM dose of Havrix, his first 20mcg IM dose of Engerix-B and a .5 cc IM dose of tetanus-diphtheria vaccine. Fortyeight hours following vaccination, the vaccinee complained of pain in liver. This symptom was subsequently reported as abdominal pain right side under rib. Two weeks later, the vaccinee was seen by a physician. The vacinee ha ddiscomfort at this time. A CT scan, and a liver enzymes study on approx. 04/13/2000 were normal. No durgs were used to treat the adverse event. The abdominal pain resolved in nine days, on 04/23/2001. The reporting nurse stated that the abdominal pain was moderate in intensity and possibly related to Engerix-B. The physician recommended that the vaccinee not continue with follow-up vaccines. As of 06/20/2001, the event resolved.
3/23/21 1st dose had tingling in my fingers of left arm/injection arm the evening of vaccine and sore arm for several days.  Nothing that disrupted anything other than sleeping on left arm 4/20/2021 2nd dose chills began evening of vaccine along with tingling fingers. the next day I experienced fatigue, headache , muscle pain, joint pain chills, nausea, loss of appetite, sore left arm with some swelling around injection site.  I was not able to work 4/21 and also missed work 4/22 but side effects were much better; not so tired but headache continued.  Took Tylenol and headache improved.
I started to develop a really bad case of psoriasis; it covered a third of my body. It turned to cellulitis. My heart rhythm problem returned that had been under control since September after my ablation, I also developed bronchitis, a severe migraine. All of this combined landed me in the hospital by January 5, 2023, where I stayed for four days. I went to the emergency room because of the cellulitis, I cannot recall the tests that were ran but I was admitted to the hospital to be treated for the cellulitis, and to help me continue to get over the bronchitis.
3 days after 2nd booster he developed significant cervical adenopathy which is progressively worsening over the last month he now feels like his airway is being impinged upon causing difficulty swallowing Lymph nodes palpation r cervical lymph 10 cm in diameter L cervical lymph 7 cm in diameter. He has a left axillary lymph node which is probably 4 cm in diameter r axillary is 3 cm in diameter R ceclavin lymph node is 2-3 cm in diameter. no airway edema. no stridor. he received steroids today. pt. has been using albuterol that makes him feel it is easier to breathe. pt was seen at our walk in clinic 3 times since vaccine was given.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; piroxicam (PAXIL [PIROXICAM]), (Batch/Lot number: unknown). The patient's relevant medical history included: "Known allergies: Shellfish" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 22Apr2022 to 27Apr2022. The patient finished the antiviral meds on Wednesday 27Apr2022 and was feeling great. On 01May2022, the patient experienced the cold symptoms with a vengeance.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Localized red rash, raised and sensitive to touch. Cephalexin 500mg TID x 7 days.
High fever, seizures (2), rash, fussy, nosebleed, won't eat, projectile vomiting, spaced out, agitated, right side mouth droops, constantly flapping hands, sick, not happy.
Narrative:  71 yo M, received dose #1 of the Moderna COVID-19 vaccine on 3/2/2021 (Lot#: 001A21A; Exp Date: 08/16/2021). On 02/26/2021, patient reported symptoms including SOB, malaise, myalgia, nausea, hematuria, and L flank pain. Patient called health care system on 3/1/2021 to inquire if patient may receive COVId-19 vaccine when he has a UTI. On 3/2/2021, nurse documented that patient denied COVID-related symptoms. Received dose #1 Moderna COVID-19 vaccine on 3/2/2021. On 3/3/2021, patient presented to emergency department due to worsening symptoms and tested positive for COVID-19 and subsequently admitted into hospital. Patient received convalescent plasma on 3/3/2021. Throughout hospital course, patient developed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia later complicated by right upper lobe PE with pulmonary hemorrhage and superimposed VAP and associated E. coli bacteremia. Reaction classified as severe as death occurred following vaccination.
November my mom began having  problems with fatigue, shortness of breath and chest pain. She went to ER and had elevated troponins and more cardiac work up revealed valvular heart failure. She required a mechanical valve in December, and then had a stroke and brain bleed. She is in a medical center. She likely had myocarditits causing heart inflammation and heart  valve  failure that caused her to go into congestive heart failure.
Seen 2 wks after DTAP and Hep-A was given. Both legs noted to have deep hives, itchy and hyperpigmented area. Noted several hours after vaccine. Persist now for over 1 month time period.
Nausea and vomiting, dizziness, achiness, chills and sweats.
pt stated he was experiencing dizzy spells and didn't know if he would be able to continue his shift at work
CHEST PAIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 04219-21A,  expiry: UNKNOWN) dose was not reported, administered on 28-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAY-2021, the subject experienced chest pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of chest pain was not reported. This report was non-serious.
Hives all over the body, which started a month after the vaccination series; This is a spontaneous report received from a contactable nurse, the patient. A 48-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown, Expiration date: not reported), via an unspecified route of administration in arm left on 10Feb2021 at 10:30 AM (at the age of 48-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, the patient was not pregnant at time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 00:00, the patient experienced hives all over the body, which started a month after the vaccination series. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Treatment was not received for the event. On 25May2021, the patient underwent lab tests and procedures which included nasal swab (SARS-CoV-2 test), resulted as negative. The outcome of the event was recovering.  The lot number for [BNT162B2], was not provided and will be requested during follow up.
Soreness; Redness; Rash; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (Soreness), ERYTHEMA (Redness) and RASH (Rash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for an unknown indication.     The patient's past medical history included No adverse event. Concomitant products included CAPTOPRIL (ANGIOPRIL [CAPTOPRIL]), LEVOTHYROXINE, DENOSUMAB (PROLIA), ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM and VITAMIN D NOS.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN (Soreness), ERYTHEMA (Redness) and RASH (Rash). At the time of the report, PAIN (Soreness), ERYTHEMA (Redness) and RASH (Rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment information  provided
About 15 minutes after receiving the second dose of the Pfizer vaccine at Clinic, patient began complaining that she was dizzy and nauseated.  Patient was seated on the exam table at this time, and was helped to lay down on the exam table. Vitals were obtained by RN. Patient began complaining of tingling of her lips while vitals were being obtained at 1110.  PA was notified and brought to the room to evaluate patient. Patient denied having any difficulty breathing or swallowing, was not experiencing any itching of the mouth, tongue or throat, and did not notice anything else unusual, patient was still dizzy and nauseated. Patient stated that she had a similar reaction to the first dose of the Pfizer COVID vaccine, where the symptoms resolved within about an hour.  Nursing staff and PA stayed with patient during the duration of her observation. Patients vitals ranged betwen pulse ox = 98-99%, pulse = 97-106 bpm, B/P = 114-121/80-89 mm hg. Patient also complained of some tingling around the lower jaw at 1147. Patient was observed for 1 hour and 26 minutes after vaccination was received. Symptoms gradually resolved, upon discharge patients lightheadedness had resolved, and the tingling around the lips and jaw were mostly gone. Patient still was not having any shortness of breath, chest pain, trouble breathing, rash or hives, swelling/tingling/numbess of the tongue, mouth, or throat. Discharge instructions were provided by PA, including when to seek further care at the ER or to call 911. Patient felt comfortable driving herself home and left at 1214.  About two hours later, pt presented to ED. Pt endorsed throat tingling, lightheaded, nausea. She also stated that while the reaction post Dose 1 and Dose 2 were similar, the reaction after Dose 2 was much more severe. Assessed for transient Bell's Palsy presentation but determined unlikely as no facial asymmetry or deficits were appreciated. RR 24, other vitals WNL. Pt observed for about 1.5 hours before discharging home with instructions to call ED should condition worsen.
Patient inadvertently administered 1st dose of Moderna cov 19 vaccine to person under the age of 18. Patient administered 2nd dose of Moderna cov 19 vaccine on 3/3/2021 with approval of health officials,
Mom called to report that pt was fussy and had vomited once or twice about six hours after vaccine Hib given.  Mom advised to monitor hydration and give Tylenol for pain/fever.
The patient was given the incorrect vaccine. Patient should of been given Tdap ( Adacel ). He was given Tdap ( Boostrix ) for adolescent use only